Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Price

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Pharmacy and Pharmacology|May 18, 2018
Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations - a PEARRL reviewDaniel J Price, Felix Ditzinger, Niklas J Koehl, et al.
The Journal of Pharmacy and Pharmacology|July 7, 2018
Application of the solubility parameter concept to assist with oral delivery of poorly water-soluble drugs - a PEARRL reviewSandra Jankovic, Georgia Tsakiridou, Felix Ditzinger, et al.
The Journal of Pharmacy and Pharmacology|August 3, 2018
Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches - a PEARRL reviewFelix Ditzinger, Daniel J Price, Alexandra-Roxana Ilie, et al.
Journal of Chemical Information and Modeling|September 11, 2025
Practically Significant Method Comparison Protocols for Machine Learning in Small Molecule Drug DiscoveryJeremy R Ash, Cas Wognum, Raquel Rodríguez-Pérez, et al.
Scientific Reports|July 19, 2018
Small molecule inhibition of RAS/MAPK signaling ameliorates developmental pathologies of Kabuki SyndromeI-Chun Tsai, Kelly McKnight, Spencer U McKinstry, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2014
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B proteinVincent W-F Tai, Dulce Garrido, Daniel J Price, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitorsKirk L Stevens, Michael J Reno, Jennifer B Alberti, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
Journal of Medicinal Chemistry|February 15, 2019
Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV InhibitorPek Y Chong, J Brad Shotwell, John Miller, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical CharacterizationJ Brad Shotwell, Subramanian Baskaran, Pek Chong, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacy and Pharmacology|May 18, 2018
Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations - a PEARRL reviewDaniel J Price, Felix Ditzinger, Niklas J Koehl, et al.
The Journal of Pharmacy and Pharmacology|July 7, 2018
Application of the solubility parameter concept to assist with oral delivery of poorly water-soluble drugs - a PEARRL reviewSandra Jankovic, Georgia Tsakiridou, Felix Ditzinger, et al.
The Journal of Pharmacy and Pharmacology|August 3, 2018
Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches - a PEARRL reviewFelix Ditzinger, Daniel J Price, Alexandra-Roxana Ilie, et al.
Journal of Chemical Information and Modeling|September 11, 2025
Practically Significant Method Comparison Protocols for Machine Learning in Small Molecule Drug DiscoveryJeremy R Ash, Cas Wognum, Raquel Rodríguez-Pérez, et al.
Scientific Reports|July 19, 2018
Small molecule inhibition of RAS/MAPK signaling ameliorates developmental pathologies of Kabuki SyndromeI-Chun Tsai, Kelly McKnight, Spencer U McKinstry, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2014
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B proteinVincent W-F Tai, Dulce Garrido, Daniel J Price, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitorsKirk L Stevens, Michael J Reno, Jennifer B Alberti, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
Journal of Medicinal Chemistry|February 15, 2019
Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV InhibitorPek Y Chong, J Brad Shotwell, John Miller, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical CharacterizationJ Brad Shotwell, Subramanian Baskaran, Pek Chong, et al.
Pageof 5